Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

ABSTRACT Due to the urgent need of a therapeutic treatment for coronavirus (CoV) disease 2019 (COVID-19) patients, a number of FDA-approved/repurposed drugs have been suggested as antiviral candidates at clinics, without sufficient information. Furthermore, there have been extensive debates over ant...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Su-Jin Park, Kwang-Min Yu, Young-Il Kim, Se-Mi Kim, Eun-Ha Kim, Seong-Gyu Kim, Eun Ji Kim, Mark Anthony B. Casel, Rare Rollon, Seung-Gyu Jang, Min-Hyeok Lee, Jae-Hyung Chang, Min-Suk Song, Hye Won Jeong, Younho Choi, Weiqiang Chen, Woo-Jin Shin, Jae U. Jung, Young Ki Choi
Formato:	article
Lenguaje:	EN
Publicado:	American Society for Microbiology 2020
Materias:	COVID-19 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antiviral therapeutics immunosuppression serum neutralization ferrets Microbiology QR1-502
Acceso en línea:	https://doaj.org/article/838b82e09b8e44308365a93fa9f4ed29
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Sea el primero en dejar un comentario!

Antiviral Efficacies of FDA-Approved Drugs against SARS-CoV-2 Infection in Ferrets

Ejemplares similares